-
Je něco špatně v tomto záznamu ?
Alemtuzumab: Rare serious adverse events of a high-efficacy drug
Hans-Peter Hartung, Jan Mares, Michael H. Barnett
Multiple sclerosis news.
2021 ;
8 (1) :
13-16.
Status minimální Jazyk angličtina Země Česko
Perzistentní odkaz
https://www.medvik.cz/link/bmc21028520
Bibliografie atd.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028520
- 003
- CZ-PrNML
- 005
- 20211111114150.0
- 007
- ta
- 008
- 211111s2021 xr f 000 0|eng||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hartung, Hans-Peter $7 nlk20050167624 $u Department of Neurology, UKD and Center for Neurology and Neuropsychiatry, LVR Klinikum, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
- 245 10
- $a Alemtuzumab: Rare serious adverse events of a high-efficacy drug / $c Hans-Peter Hartung, Jan Mares, Michael H. Barnett
- 504 __
- $a Literatura
- 700 1_
- $a Mareš, Jan $7 xx0060341 $u Department of Neurology, Palacky University Olomouc, Czech Republic
- 700 1_
- $a Barnett, Michael H. $u Department of Neurology, Royal Prince Alfred Hospital and Brain and Mind Center, The University of Sydney, Australia
- 773 0_
- $t Multiple sclerosis news $x 2464-5389 $g Roč. 8, č. 1 (2021), s. 13-16 $w MED00187883
- 910 __
- $a ABA008 $b B 2762 $c 616 c $y 0 $z 0
- 990 __
- $a 20211111110006 $b ABA008
- 991 __
- $a 20211111114149 $b ABA008
- 999 __
- $a min $b bmc $g 1721901 $s 1149067
- BAS __
- $a 3
- BMC __
- $a 2021 $b 8 $c 1 $d 13-16 $i 2464-5389 $m Multiple sclerosis news $x MED00187883
- LZP __
- $a NLK 2021-46/kv
